Association of first trimester maternal serum analytes with adverse pregnancy outcomes 1 year obseravtional study at KAHERS Dr. Prabhakar Kore hospital and medical research cetre
Not Applicable
- Conditions
- Health Condition 1: O351- Maternal care for (suspected) chromosomal abnormality in fetus
- Registration Number
- CTRI/2022/06/043093
- Lead Sponsor
- Dr Cheyne Rosetta Estibeiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)All pregnant women between 9 weeks and 13 weeks 6 days POG presenting for the first trimester visit to OPD
2)Participants who are consenting for enrollment in the study
Exclusion Criteria
1)women with major ultrasonic or chromosomal abnormalities
2)k/c/o insulin dependent diabetes mellitus
3)chronic hypertension
4)cardiac disorder
5)renal disorder
6)multiple gestation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to assess the association between Beta HCG PLGF and associated PAPP A From 12 weeks period of gestation until 13 weeks 6 days period of gestation with adverse pregnancy outcomes such as preeclampsia, FGR, Pre term delivery, Oligohydramnios, low birth weight, abruptio placenta, Intra uterine death, chromosomal anomalies.Timepoint: From 12 weeks period of gestation until 13 weeks 6 days period of gestation <br/ ><br>next post delivery in peurperium
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI